Aquestive Therapeutics, Inc. Business Finance Contracts & Agreements
33 Contracts & Agreements
- Credit Agreements (4 contracts)
- Equity Distribution Agreements (1)
- Indenture Agreements (6)
- Note Agreements (2)
- Purchase Agreements (5)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (3)
- Waiver Agreements (1)
- Warrant Agreements (3)
- Underwriting Agreement, dated March 19, 2024, by and among Aquestive Therapeutics, Inc. and Leerink Partners LLC and Piper Sandler & Co., as representatives of the several... (Filed With SEC on March 21, 2024)
- Form of Securities Purchase Agreement dated June 6, 2022, by and among Aquestive Therapeutics, Inc. and the purchasers (Filed With SEC on June 8, 2022)
- Form of Common Stock Warrant (Filed With SEC on June 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on June 8, 2022)
- Amendment No. 2 to the Purchase Agreement, dated as of May 13, 2022, by and among the Aquestive Therapeutics, Inc. and the Purchasers signatory thereto (Filed With SEC on May 17, 2022)
- Fifth Supplemental Indenture, dated May 13, 2022, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank Trust Company, National... (Filed With SEC on May 17, 2022)
- Registration Rights Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
- Purchase Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
- Fourth Supplemental Indenture, dated October 7, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association,... (Filed With SEC on October 8, 2021)
- Waiver Agreement dated as of September 30, 2021, among Aquestive Therapeutics, Inc., at the Noteholder party thereto (Filed With SEC on October 6, 2021)
- Third Supplemental Indenture, dated August 6, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association, as... (Filed With SEC on August 9, 2021)
- Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on March 26, 2021)
- Purchase and Sale Agreement, dated as of November 3, 2020, by and between Aquestive Therapeutics, Inc. and MAM Pangolin Royalty, LLC (Filed With SEC on March 9, 2021)
- Form of 2020 Purchase Agreement in connection with the 2020 issuance of 12.5% Senior Secured Notes (Filed With SEC on March 9, 2021)
- Second Supplemental Indenture dated November 20, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association,... (Filed With SEC on March 9, 2021)
- First Supplemental Indenture dated November 3, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as... (Filed With SEC on March 9, 2021)
- Paycheck Protection Program Promissory Note dated April 17, 2020, between Aquestive Therapeutics, Inc., as Borrower, and Frost Bank, as Lender (Filed With SEC on April 20, 2020)
- Aquestive Therapeutics, Inc. Employee Stock Purchase Plan as Amended (Filed With SEC on March 11, 2020)
- Underwriting Agreement, dated December 12, 2019, by and between Aquestive Therapeutics, Inc. and BMO Capital Markets Corp., as representative of the several underwriters named... (Filed With SEC on December 16, 2019)
- Indenture Dated as of July 15, 2019, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as Trustee and... (Filed With SEC on July 16, 2019)
- Form of Purchase Agreement (Filed With SEC on July 16, 2019)
- Form of Warrant (Filed With SEC on July 16, 2019)
- Aquestive Therapeutics, Inc. Employee Stock Purchase Plan (Filed With SEC on June 18, 2019)
- Form of Underwriting Agreement (Filed With SEC on July 16, 2018)
- Form of Stock Option Agreement dated April 2018 (Filed With SEC on June 27, 2018)
- Amendment No. 2 to Credit Agreement and Guaranty dated May 21, 2018, by and between Aquestive Therapeutics, Inc. and Perceptive Credit Opportunities Fund, LP (Filed With SEC on June 27, 2018)
- Omnibus Amendment No. 1 dated January 1, 2018, by and between Monosol Rx, LLC, the Lenders party thereto and Perceptive Credit Holdings, LP (Filed With SEC on June 27, 2018)
- Credit Agreement and Guaranty dated August 16, 2016, by and between Monosol Rx, LLC and Perceptive Credit Opportunities Fund, LP (Filed With SEC on June 27, 2018)
- Registration Rights Agreement, dated June 24, 2016, by and between Aquestive Partners, LLC and certain of the holders of its membership interests (Filed With SEC on June 27, 2018)
- Warrant to Purchase 11,625,437 senior common equity interests to Perceptive Credit Holdings, LP, dated as of January 1, 2018 (Filed With SEC on June 27, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on June 27, 2018)
- MONOSOL Rx, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on August 29, 2007)
- SEPARATIONAGREEMENT AND GENERAL RELEASE (Filed With SEC on July 25, 2007)
